NYKODE TOLERANCE NORWAY AS
934454618ActivePioneering immunotherapy platform unlocking future medicine for serious diseases.
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2024
- Grundat
Nyckelbeslutsfattare
Michael Engsig
Chief Executive Officer
Agnete B. Fredriksen
Chief Scientific Officer & Business Development
Harald Gurvin
Chief Financial Officer
Louise Stubbe
Chief Legal Officer
Beskrivning
Nykode Therapeutics ASA is a biotechnology company dedicated to advancing human health through innovative medical science. The core of their operation is the proprietary Vaccibody molecule, which forms an unrivalled modular technology platform. This platform is designed to induce fast, strong, and l...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Okänt
Beslutsfattare
4 kontakter i FunnelfeedrMichael Engsig
Chief Executive Officer
Agnete B. Fredriksen
Chief Scientific Officer & Business Development
Harald Gurvin
Chief Financial Officer
Louise Stubbe
Chief Legal Officer
Liknande företag
20 liknande företag i FunnelfeedrINCYTE BIOSCIENCES NORWAY AS
Global biopharmaceutical company developing innovative medicines for patients.
CELLMOVER AS
6 anställdaPre-clinical immunotherapy company optimizing immune cell targeting for cancer.
ROCHE DIAGNOSTICS NORGE AS
100 anställdaGlobal leader in pharmaceuticals and diagnostics driving personalized medicine.
ROCHE NORGE AS
46 anställdaGlobal leader pioneering personalized medicine through pharmaceuticals and diagnostics.
Oncotech Nordic AB
0 anställdaDeveloping AI diagnostics and immunotherapy to conquer global cancer.
Utforska mer
Frågor om NYKODE TOLERANCE NORWAY AS
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo